Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

118.61
+3.322.88%
Post-market: 118.610.00000.00%19:14 EDT
Volume:1.21M
Turnover:142.19M
Market Cap:17.36B
PE:10.61
High:118.77
Open:115.02
Low:114.66
Close:115.29
Loading ...

Biogen price target lowered to $144 from $175 at Stifel

TIPRANKS
·
13 Feb

Stifel Nicolaus Adjusts Biogen Price Target to $144 From $175, Maintains Hold Rating

MT Newswires Live
·
13 Feb

Sage Therapeutics' Q4 Earnings Miss Mark, Revenues Plunge Y/Y

Zacks
·
13 Feb

Biogen Stock Falls After Company Gives Weaker-Than-Expected Financial Outlook -- WSJ

Dow Jones
·
12 Feb

BUZZ-Royalty Pharma falls after investing $250 mln in Biogen's lupus treatment

Reuters
·
12 Feb

Stock Track | Biogen's Stock Plummets 6.5% as Weak 2025 Outlook Overshadows Alzheimer's Drug Strength

Stock Track
·
12 Feb

Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

Benzinga
·
12 Feb

Biogen Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Feb

Biogen (BIIB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
·
12 Feb

Royalty Pharma to Provide up to $250 Million to Biogen for Litifilimab R&D

MT Newswires Live
·
12 Feb

BIIB Earnings: Biogen Hails Alzheimer’s Drug Leqembi as New Treatments Drive Earnings Beat

TIPRANKS
·
12 Feb

Biogen Inc. (BIIB) Q4 Earnings and Revenues Surpass Estimates

Zacks
·
12 Feb

Biogen's stock hit by soft guidance and a decline in sales of MS drugs

Dow Jones
·
12 Feb

Biogen Inc (BIIB) Q4 2024 Earnings: EPS of $3.44 and Revenue of $2.5 Billion Surpass Estimates

GuruFocus
·
12 Feb

Biogen's Q4 Non-GAAP Earnings, Revenue Rise; 2025 Outlook Set

MT Newswires Live
·
12 Feb

Biogen 4Q Revenue Tops Wall Street's Estimates

Dow Jones
·
12 Feb

BUZZ-Biogen falls on weak 2025 profit forecast

Reuters
·
12 Feb

GUIDANCE: (BIIB) Biogen Expects Full Year 2025 Adjusted EPS Range $15.25 - $16.25, vs. FactSet Est of $16.33

MT Newswires Live
·
12 Feb

Earnings Flash (BIIB) Biogen Posts Q4 Revenue $2.46 Billion, vs. FactSet Est of $2.41 Billion

MT Newswires Live
·
12 Feb

BRIEF-Biogen Q4 Adjusted EPS USD 3.44 Vs. IBES Estimate USD 3.35

Reuters
·
12 Feb